25 June 2022 : Clinical Research
Serum TP53 Protein Level as a Sensitive Biomarker for the Diagnosis of Myocardial Damage in Children
Xianglin Zeng1EF, Chunwang Lin1AEG*, Yanna Sun1BD, Jianping Zhang1CFDOI: 10.12659/MSM.936248
Med Sci Monit 2022; 28:e936248
Figure 1 (A–C) Association between TP53 levels and NT-proBNP, cTnI, and CK-MB levels in patients younger than 18 years and with secondary myocardial damage (r=0.637, r=0.815 and r=0.697; P<0.001 for all). Figures were generated using GraphPad software (GraphPad Software, La Jolla, CA, USA).